About Oculyze
Oculyze is a company based in Wildau (Germany) founded in 2016 by Ulrich Martin Tillich and Katja Schulze. Oculyze has raised $2.5 million across 4 funding rounds from investors including European Union, CNB Capital and Brandenburg Capital. Oculyze operates in a competitive market with competitors including PathAI, Deepcell, Aignostics, Definiens and Pictor Labs, among others.
- Headquarter Wildau, Germany
- Founders Ulrich Martin Tillich, Katja Schulze
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Oculyze Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.5 M (USD)
in 4 rounds
-
Latest Funding Round
$2.5 M (USD), Seed
Sep 01, 2022
-
Investors
European Union
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Oculyze
Oculyze has successfully raised a total of $2.5M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $2.5 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Oculyze
Oculyze has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, CNB Capital and Brandenburg Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CNB Capital is engaged in technology-driven venture capital investments.
|
Locked | Locked | Locked | |
|
Investments are directed by Brandenburg Capital toward multiple sectors.
|
Locked | Locked | Locked | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked |
Investor details for Oculyze
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oculyze
Investment portfolio details for Oculyze
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Oculyze
Detailed financials for Oculyze
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oculyze Comparisons
Peer comparison for Oculyze
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oculyze
Oculyze operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Deepcell, Aignostics, Definiens and Pictor Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| Locked | Locked | Locked |
AI-powered single cell classification and isolation technology for clinical research
|
|
| Locked | Locked | Locked |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| Locked | Locked | Locked |
Provides image analysis and data mining solutions for quantitative digital pathology in the healthcare industry
|
|
| Locked | Locked | Locked |
AI-based tools for pathological image analysis are provided to labs.
|
|
| Locked | Locked | Locked |
Platform offering solutions for preventive health scans
|
Detailed competitors of Oculyze
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oculyze
Complete news archive for Oculyze
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oculyze
Oculyze was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Oculyze is headquartered in Wildau, Germany. It is registered at Wildau, Brandenburg, Germany.
Ulrich Martin Tillich is the current CEO of Oculyze. They have also founded this company.
Oculyze is a funded company, having raised a total of $2.5M across 4 funding rounds to date.
Oculyze was founded in 2016 and is based in Wildau, Germany. AI-driven software solutions are developed for the winery industry, focusing on operational enhancements and data analysis. Services include custom software tailored to vineyard management and production processes. The company is led by co-founders Ulrich Martin Tillich and Katja Schulze, who serve as co-CEOs. Operations center on supporting wineries through technology integration across Europe.
Oculyze's top competitors include Aignostics, Pictor Labs and PathAI.
Oculyze has 5 investors. Key investors include European Union, CNB Capital, Brandenburg Capital, EIC Fund, and British International Investment.